BACKGROUND: Post-treatment attention problems experienced by pediatric cancer survivors have been described as similar to symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) experienced in physically healthy children. Accordingly, the objectives of this study were to: (a) estimate the rate of occurrence of ADHD and secondary ADHD (SADHD) in a sample of pediatric cancer survivors, (b) compare the rate of ADHD/SADHD among survivors to the prevalence of ADHD in the general population, and (c) examine clinical correlates of ADHD/SADHD in this sample. PROCEDURE: Survivors of pediatric ALL or brain tumor (n = 100) participated in an assessment of attention including a Computerized Performance Measure [Conners' Continuous Performance test-II (CPT-II)], parent and self-report measures (Conners 3), and a structured diagnostic interview for ADHD and other psychological disorders [Diagnostic Interview for Children and Adolescents-IV (DICA-IV)]. RESULTS: Binomial tests revealed that the rate of ADHD/SADHD in our sample (9%) was significantly greater than the lower limits of ADHD prevalence among children in the US (3%; P < 0.001), while no difference was identified compared to the upper limits of ADHD prevalence (7%; P > 0.05). Many additional survivors (>25% of the sample) obtained clinical elevations on Conners 3 scales but did not meet ADHD/SADHD criteria. CONCLUSIONS: Attentional deficits experienced by pediatric cancer survivors do not appear to resemble the clinical presentation of ADHD or SADHD. Many survivors with cognitive and behavioral difficulties related to attention were not identified using this diagnostic approach. Findings offer needed clarification to guide researchers and clinicians in conceptualizing, assessing, and intervening on attentional late effects.
BACKGROUND: Post-treatment attention problems experienced by pediatric cancer survivors have been described as similar to symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) experienced in physically healthy children. Accordingly, the objectives of this study were to: (a) estimate the rate of occurrence of ADHD and secondary ADHD (SADHD) in a sample of pediatric cancer survivors, (b) compare the rate of ADHD/SADHD among survivors to the prevalence of ADHD in the general population, and (c) examine clinical correlates of ADHD/SADHD in this sample. PROCEDURE: Survivors of pediatric ALL or brain tumor (n = 100) participated in an assessment of attention including a Computerized Performance Measure [Conners' Continuous Performance test-II (CPT-II)], parent and self-report measures (Conners 3), and a structured diagnostic interview for ADHD and other psychological disorders [Diagnostic Interview for Children and Adolescents-IV (DICA-IV)]. RESULTS: Binomial tests revealed that the rate of ADHD/SADHD in our sample (9%) was significantly greater than the lower limits of ADHD prevalence among children in the US (3%; P < 0.001), while no difference was identified compared to the upper limits of ADHD prevalence (7%; P > 0.05). Many additional survivors (>25% of the sample) obtained clinical elevations on Conners 3 scales but did not meet ADHD/SADHD criteria. CONCLUSIONS:Attentional deficits experienced by pediatric cancer survivors do not appear to resemble the clinical presentation of ADHD or SADHD. Many survivors with cognitive and behavioral difficulties related to attention were not identified using this diagnostic approach. Findings offer needed clarification to guide researchers and clinicians in conceptualizing, assessing, and intervening on attentional late effects.
Authors: B B Lahey; W E Pelham; E A Schaughency; M S Atkins; H A Murphy; G Hynd; M Russo; S Hartdagen; A Lorys-Vernon Journal: J Am Acad Child Adolesc Psychiatry Date: 1988-05 Impact factor: 8.829
Authors: R Klorman; L O Bauer; H W Coons; J L Lewis; J Peloquin; R A Perlmutter; R M Ryan; L F Salzman; J Strauss Journal: Psychopharmacol Bull Date: 1984
Authors: David A Pineda; Luis Guillermo Palacio; Isabel C Puerta; Vilma Merchán; Clara P Arango; Astrid Yuleth Galvis; Mónica Gómez; Daniel Camilo Aguirre; Francisco Lopera; Mauricio Arcos-Burgos Journal: Eur Child Adolesc Psychiatry Date: 2007-08 Impact factor: 4.785
Authors: Heather M Conklin; Raja B Khan; Wilburn E Reddick; Susan Helton; Ronald Brown; Scott C Howard; Melanie Bonner; Robbin Christensen; Shengjie Wu; Xiaoping Xiong; Raymond K Mulhern Journal: J Pediatr Psychol Date: 2007-06-14
Authors: Kimberly P Raghubar; Jessica Orobio; M Douglas Ris; Andrew M Heitzer; Alexandra Roth; Austin L Brown; M Fatih Okcu; Murali Chintagumpala; David R Grosshans; Arnold C Paulino; Anita Mahajan; Lisa S Kahalley Journal: Pediatr Blood Cancer Date: 2019-05-27 Impact factor: 3.167
Authors: Amanda L Winter; Heather M Conklin; Vida L Tyc; Heather Stancel; Pamela S Hinds; Melissa M Hudson; Lisa S Kahalley Journal: J Clin Exp Neuropsychol Date: 2014-08-15 Impact factor: 2.475
Authors: Tara M Brinkman; Chenghong Li; Kathryn Vannatta; Jordan G Marchak; Jin-Shei Lai; Pinki K Prasad; Cara Kimberg; Stefanie Vuotto; Chongzhi Di; Deokumar Srivastava; Leslie L Robison; Gregory T Armstrong; Kevin R Krull Journal: J Clin Oncol Date: 2016-07-18 Impact factor: 44.544
Authors: Lisa S Kahalley; Heather M Conklin; Vida L Tyc; Melissa M Hudson; Stephanie J Wilson; Shengjie Wu; Xiaoping Xiong; Pamela S Hinds Journal: Psychooncology Date: 2013-02-28 Impact factor: 3.894
Authors: Victoria W Willard; Kristina K Hardy; Taryn M Allen; Eugene I Hwang; Sridharan Gururangan; Sarah A Hostetter; Melanie J Bonner Journal: J Neurooncol Date: 2013-05-10 Impact factor: 4.130
Authors: Kristina K Hardy; Victoria W Willard; Anthony Gioia; Christina Sharkey; Karin S Walsh Journal: Neuro Oncol Date: 2018-04-09 Impact factor: 12.300